1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Product description

The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development pipeline of novel recombinant and purified FSH, hCG and LH receptor agonists for treatment of infertility.

Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report provides information on the marketed FSH, hCG and LH preparations and includes a compilation of current active projects in research and development of novel FSH, LH and hCG receptor agonists. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects.

Competitor projects are listed in a tabular format providing information on:

Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Company,
Product Category,
Indication,
R&D Stage and
additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Table of Contents

Urinary FSH-Containing Products: Menotropins
Recombinant Menotropins
1st Generation Purified Human Urinary FSH
2nd Generation Recombinant Human FSH
Biosimilar Recombinant Human FSH
2nd Generation Rhu FSH in Non-Regulated Markets
3rd Generation Rhu FSH
Purified Urinary Human Choriogonadotropin (hCG)
Recombinant Human Choriogonadotropin (rhCG)
Recombinant Human Luteinizing Hormone (rhLH)
hCG Receptor Agonist
Corporate FSH, LH and hCG Product Portfolios and RandD Pipelines

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global protein labeling market is expected to reach USD 1,894.5 million by 2020 from USD 1,089.5 million in 2015, at a CAGR of 11.7% from 2015 to 2020. On the basis of products, the protein labeling ...

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Global Pea Protein Market

October 2016 $ 4250

Download Unlimited Documents from Trusted Public Sources

Protein Industry in the US

  • December 2016
    18 pages
  • Protein  

  • United States  

View report >

Influenza Statistics in the US

  • November 2016
    7 pages
  • Influenza  

    Influenza Vacci...  

    Vaccine  

  • United States  

View report >

Influenza Statistics in France

  • November 2016
    23 pages
  • Influenza  

    Infectious Dise...  

    Vaccine  

  • France  

    Europe  

View report >

Related Market Segments :

Protein

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.